ALEMTUZUMAB AS COMPARED TO ALTERNATIVE CONTEMPORARY INDUCTION REGIMENS

Between 1/1/02 and 12/31/07, our center performed 1687 adult renal transplants. A retrospective analysis was performed to compare outcomes between patients receiving alemtuzumab (n=632) and those receiving either basiliximab (n=690) or thymoglobulin (n=125). Patients receiving alemtuzumab were young...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: LaMattina, John C., Mezrich, Joshua D., Foley, David P., D’Alessandro, Anthony M., Sollinger, Hans W., Pirsch, John D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3665410/
https://ncbi.nlm.nih.gov/pubmed/22394259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1432-2277.2012.01448.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller